{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:43:06Z","timestamp":1790995386339,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1053\/ejso.2002.1328","type":"journal-article","created":{"date-parts":[[2002,12,10]],"date-time":"2002-12-10T20:48:30Z","timestamp":1039553310000},"page":"875-890","source":"Crossref","is-referenced-by-count":30,"title":["Isolated liver perfusion for non-resectable liver tumours: a review"],"prefix":"10.1053","volume":"28","author":[{"given":"D.","family":"Christoforidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Martinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Mosimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/ejso.2002.1328_RF1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00000658-198405000-00002","article-title":"The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment","volume":"199","author":"Wagner","year":"1984","journal-title":"Ann Surg"},{"key":"10.1053\/ejso.2002.1328_RF2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/bjs.1800560217","article-title":"Prognosis of carcinoma of the large bowel in the presence of liver metastases","volume":"56","author":"Oxley","year":"1969","journal-title":"Br J Surg"},{"key":"10.1053\/ejso.2002.1328_RF3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0002-9610(67)90206-1","article-title":"Hepatic resection for metastatic cancer","volume":"113","author":"Flanagan","year":"1967","journal-title":"Am J Surg"},{"key":"10.1053\/ejso.2002.1328_RF4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/02841860151116367","article-title":"A systematic overview of chemotherapy effects in colorectal cancer","volume":"40","author":"Ragnhammar","year":"2001","journal-title":"Acta Oncol"},{"key":"10.1053\/ejso.2002.1328_RF5","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"de Gramont","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1328_RF6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200009283431302","article-title":"Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group","volume":"343","author":"Saltz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/ejso.2002.1328_RF7","first-page":"3393","article-title":"Development of a technique for isolated perfusion of the liver","volume":"61","author":"Ausmann","year":"1961","journal-title":"N Y State J Med"},{"key":"10.1053\/ejso.2002.1328_RF8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1200\/JCO.1992.10.1.52","article-title":"High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma","volume":"10","author":"Lienard","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1328_RF9","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/bjs.1800821034","article-title":"Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Francaise de Cancerologie Digestive","volume":"82","author":"Rougier","year":"1995","journal-title":"Br J Surg"},{"key":"10.1053\/ejso.2002.1328_RF10","first-page":"969","article-title":"The blood supply of neoplasms in the liver","volume":"30","author":"Breedis","year":"1954","journal-title":"Am J Pathol"},{"key":"10.1053\/ejso.2002.1328_RF11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/JCO.2000.18.2.239","article-title":"Waiting for the definitive trial of hepatic arterial chemotherapy for colorectal cancer","volume":"18","author":"Haller","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1328_RF12","first-page":"2285","article-title":"Possible benefits of hyperthermia to chemotherapy","volume":"39","author":"Kowal","year":"1979","journal-title":"Cancer Res"},{"key":"10.1053\/ejso.2002.1328_RF13","first-page":"3944","article-title":"Selective lethal effect of supranormal temperatures on human neoplastic cells","volume":"36","author":"Giovanella","year":"1976","journal-title":"Cancer Res"},{"key":"10.1053\/ejso.2002.1328_RF14","first-page":"2075","volume":"37","year":"1976","journal-title":"Cancer"},{"key":"10.1053\/ejso.2002.1328_RF15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1054\/bjoc.1999.1027","article-title":"TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects","volume":"82","author":"van der Veen","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1053\/ejso.2002.1328_RF16","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1054\/bjoc.1999.1032","article-title":"Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion","volume":"82","author":"de Wilt","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1053\/ejso.2002.1328_RF17","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/bjc.1991.466","article-title":"Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion","volume":"64","author":"Marinelli","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1053\/ejso.2002.1328_RF18","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/bjc.1990.404","article-title":"A comparative study of isolated liver perfusion versus hepatic artery infusion with mitomycin C in rats","volume":"62","author":"Marinelli","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1053\/ejso.2002.1328_RF19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-642-82025-0_18","article-title":"First experimental and clinical results of isolated liver perfusion with cytotoxics in metastases from colorectal primary","volume":"86","author":"Aigner","year":"1983","journal-title":"Recent Results Cancer Res"},{"key":"10.1053\/ejso.2002.1328_RF20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.jjco.a023243","article-title":"Isolated liver perfusion with mitomycin C in the treatment of colorectal cancer metastases confined to the liver","volume":"26","author":"Marinelli","year":"1996","journal-title":"Jpn J Clin Oncol"},{"key":"10.1053\/ejso.2002.1328_RF21","first-page":"1539","article-title":"Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver","volume":"82","author":"Vahrmeijer","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1053\/ejso.2002.1328_RF22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-642-80460-1_9","article-title":"Phase I\/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal cancer hepatic metastases","volume":"147","author":"Marinelli","year":"1998","journal-title":"Recent Results Cancer Res"},{"key":"10.1053\/ejso.2002.1328_RF23","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1200\/JCO.1998.16.4.1479","article-title":"Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver","volume":"16","author":"Alexander","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1328_RF24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/978-3-642-80460-1_12","article-title":"Isolated hepatic perfusion with extracorpo-real oxygenation using hyperthermia TNF alpha and melphalan: Swedish experience","volume":"147","author":"Hafstrom","year":"1998","journal-title":"Recent Results Cancer Res"},{"key":"10.1053\/ejso.2002.1328_RF25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0039-6060(98)70200-4","article-title":"First experience and technical aspects of isolated liver perfusion for extensive liver metastasis","volume":"123","author":"Oldhafer","year":"1998","journal-title":"Surgery"},{"key":"10.1053\/ejso.2002.1328_RF26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00000658-199812000-00007","article-title":"Isolated hypoxic hepatic perfusion with tumor necrosis factor-alpha, melphalan, and mitomycin C using balloon catheter techniques: a pharmacokinetic study in pigs","volume":"228","author":"van Ijken","year":"1998","journal-title":"Ann Surg"},{"key":"10.1053\/ejso.2002.1328_RF27","first-page":"776","article-title":"Isolated hypoxic hepatic perfusion (IHHP) using balloon catheter techniques: from laboratory to the clinic towards a percutaneous procedure","volume":"47","author":"Eggermont","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1053\/ejso.2002.1328_RF28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9610(96)00422-9","article-title":"Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemo-perfusion for malignant liver tumors","volume":"173","author":"Ku","year":"1997","journal-title":"Am J Surg"},{"key":"10.1053\/ejso.2002.1328_RF29","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1200\/JCO.1994.12.12.2723","article-title":"Percutaneous hepatic vein isolation and high-dose hepatic arterial Infusion chemotherapy for unresectable liver tumors","volume":"12","author":"Ravikumar","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1328_RF30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF02303811","article-title":"Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study","volume":"1","author":"Curley","year":"1994","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/ejso.2002.1328_RF31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2307\/3575914","article-title":"Involvement of membranes in cellular responses to hyperthermia","volume":"92","author":"Lepock","year":"1982","journal-title":"Radiat Res"},{"key":"10.1053\/ejso.2002.1328_RF32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-4165(83)90016-8","article-title":"Thermal sensitivity and resistance of insulin-receptor binding","volume":"756","author":"Calderwood","year":"1983","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/ejso.2002.1328_RF33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0197-2456(95)00078-X","article-title":"Biological rationale and clinical experience with hyperthermia","volume":"17","author":"Engin","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1053\/ejso.2002.1328_RF34","series-title":"Hyperthermia and Cancer","author":"Hahn","year":"1982"},{"key":"10.1053\/ejso.2002.1328_RF35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/02656739409010278","article-title":"Endothelial cells and hyperthermia","volume":"10","author":"Fajardo","year":"1994","journal-title":"Int J Hyperthermia"},{"key":"10.1053\/ejso.2002.1328_RF36","first-page":"1096","article-title":"Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells","volume":"41","author":"Teicher","year":"1981","journal-title":"Cancer Res"},{"key":"10.1053\/ejso.2002.1328_RF37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s002800050721","article-title":"Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model","volume":"41","author":"Jacquet","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/ejso.2002.1328_RF38","first-page":"152","article-title":"The effect of hyperthermia and melphalan on survival of human fibroblast strains and melanoma cell lines","volume":"37","author":"Goss","year":"1977","journal-title":"Cancer Res"},{"key":"10.1053\/ejso.2002.1328_RF39","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1200\/JCO.1993.11.9.1787","article-title":"Phase I clinical trial of carboplatin and 41.8\u00b0C whole-body hyperthermia in cancer patients","volume":"11","author":"Robins","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1328_RF40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0360-3016(96)00238-6","article-title":"Local hyperthermia enhances the effect of cis-diamminedichloro-platinum(II) on nonirradiated and preirradiated rat solid tumors","volume":"36","author":"van Bree","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/ejso.2002.1328_RF41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1349-7006.1992.tb01962.x","article-title":"Mechanism of synergistic cytotoxic effect between tumor necrosis factor and hyperthermia","volume":"83","author":"Yamauchi","year":"1992","journal-title":"Jpn J Cancer Res"},{"key":"10.1053\/ejso.2002.1328_RF42","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archsurg.1986.01400110056009","article-title":"Tumoricidal effects and patient survival after hyperthermic liver perfusion","volume":"121","author":"Skibba","year":"1986","journal-title":"Arch Surg"},{"key":"10.1053\/ejso.2002.1328_RF43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/978-3-642-80460-1_4","article-title":"Hyperthermo-chemo-hypoxic isolated liver perfusion for hepatic metastases: a possible adjuvant approach","volume":"147","author":"Nakajima","year":"1998","journal-title":"Recent Results Cancer Res"},{"key":"10.1053\/ejso.2002.1328_RF44","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","article-title":"An endotoxin-induced serum factor that causes necrosis of tumors","volume":"72","author":"Carswell","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/ejso.2002.1328_RF45","first-page":"3899","article-title":"TNF alpha in isolated perfusion systems: success in the limb, developments for the liver credits, debits and future perspectives","volume":"18","author":"Eggermont","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1053\/ejso.2002.1328_RF46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-3-642-80460-1_11","article-title":"Isolated hepatic perfusion with tumor necrosis factor alpha and melphalan: experimental studies in pigs and phase I data from humans","volume":"147","author":"de Vries","year":"1998","journal-title":"Recent Results Cancer Res"},{"key":"10.1053\/ejso.2002.1328_RF47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00002371-200007000-00008","article-title":"Tumor necrosis factor-alpha augments tumor effects in isolated hepatic perfusion with melphalan in a rat sarcoma model","volume":"23","author":"van Ijken","year":"2000","journal-title":"J Immunother"},{"key":"10.1053\/ejso.2002.1328_RF48","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1067\/msy.2001.110365","article-title":"Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer","volume":"129","author":"Bartlett","year":"2001","journal-title":"Surgery"},{"key":"10.1053\/ejso.2002.1328_RF49","first-page":"3062","article-title":"A phase I\u2013II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver","volume":"6","author":"Alexander","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1053\/ejso.2002.1328_RF50","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm0498-408","article-title":"Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma","volume":"4","author":"Ruegg","year":"1998","journal-title":"Nat Med"},{"key":"10.1053\/ejso.2002.1328_RF51","first-page":"2357","article-title":"Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms","volume":"4","author":"Alexander","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1053\/ejso.2002.1328_RF52","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/tcic.8.3.142.150","article-title":"Side effects of cancer treatment with recombinant human tumour necrosis factor alpha: a new challenge for the intensive care unit","volume":"8","author":"Zwaveling","year":"1997","journal-title":"Clinical Intensive Care"},{"key":"10.1053\/ejso.2002.1328_RF53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0022-4804(90)90252-W","article-title":"Portal infusion of tumor necrosis factor increases mortality in rats","volume":"49","author":"Kahky","year":"1990","journal-title":"J Surg Res"},{"key":"10.1053\/ejso.2002.1328_RF54","doi-asserted-by":"crossref","first-page":"845, 50; discussion 851","DOI":"10.1007\/BF00299083","article-title":"Simple method of hyperthermo-chemo-hypoxic isolated liver perfusion for hepatic metastases","volume":"18","author":"Horikawa","year":"1994","journal-title":"World J Surg"},{"key":"10.1053\/ejso.2002.1328_RF55","first-page":"579","article-title":"Reduction of systemic drug exposure after hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration","volume":"114","author":"Curley","year":"1993","journal-title":"Surgery"},{"key":"10.1053\/ejso.2002.1328_RF56","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00000658-199804000-00012","article-title":"Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion","volume":"227","author":"Ku","year":"1998","journal-title":"Ann Surg"},{"key":"10.1053\/ejso.2002.1328_RF57","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJM199912303412702","article-title":"Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer","volume":"341","author":"Kemeny","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/ejso.2002.1328_RF58","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1200\/JCO.1998.16.7.2528","article-title":"Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver","volume":"16","author":"O'Connell","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1328_RF59","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s002800000254","article-title":"Sequential intrahepatic and systemic fluoropyrimidine-based chemotherapy for metastatic colorectal cancer confined to the liver. A phase II study","volume":"47","author":"Porta","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/ejso.2002.1328_RF60","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1200\/JCO.2001.19.10.2687","article-title":"Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer","volume":"19","author":"Kemeny","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1328_RF61","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/BF01655820","article-title":"Rationale and indications for perfusion in liver tumors: current data","volume":"11","author":"Schwemmle","year":"1987","journal-title":"World J Surg"},{"key":"10.1053\/ejso.2002.1328_RF62","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1067\/msy.2001.111697","article-title":"Specific organ gene transfer in vivo by regional organ perfusion with herpes viral amplicon vectors: implications for local gene therapy","volume":"129","author":"Brooks","year":"2001","journal-title":"Surgery"},{"key":"10.1053\/ejso.2002.1328_RF63","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s004330050124","article-title":"Efficiency of adenovirus-mediated gene transfer into hepatocytes by liver asanguineous perfusion method","volume":"199","author":"Futagawa","year":"2000","journal-title":"Res Exp Med (Berl)"},{"key":"10.1053\/ejso.2002.1328_RF64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0960-7404(94)90005-1","article-title":"Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy","volume":"3","author":"Hafstrom","year":"1994","journal-title":"Surg Oncol"},{"key":"10.1053\/ejso.2002.1328_RF65","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1053\/ejso.1998.0623","article-title":"Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan","volume":"25","author":"Lindner","year":"1999","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/ejso.2002.1328_RF66","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1023\/A:1008270916325","article-title":"The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK)","volume":"9","author":"Borner","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1053\/ejso.2002.1328_RF67","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1200\/JCO.1997.15.1.251","article-title":"Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy","volume":"15","author":"Rougier","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1328_RF68","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1200\/JCO.1997.15.8.2910","article-title":"Phase II trial of irinotecan in patients with metastatic colorectal carcinoma","volume":"15","author":"Pitot","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1328_RF69","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0959-8049(96)00370-X","article-title":"Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer","volume":"33","author":"de Gramont","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1053\/ejso.2002.1328_RF70","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/1097-0142(19840315)53:6<1336::AID-CNCR2820530620>3.0.CO;2-O","article-title":"Regional chemotherapy of colorectal cancer metastatic to the liver","volume":"53","author":"Niederhuber","year":"1984","journal-title":"Cancer"},{"key":"10.1053\/ejso.2002.1328_RF71","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.1983.1.5.337","article-title":"Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump","volume":"1","author":"Weiss","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1328_RF72","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.1992.10.7.1112","article-title":"Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial","volume":"10","author":"Rougier","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1328_RF73","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/88.5.252","volume":"88","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/ejso.2002.1328_RF74","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/1097-0142(19940215)73:4<1134::AID-CNCR2820730403>3.0.CO;2-V","article-title":"Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update","volume":"73","author":"Kemeny","year":"1994","journal-title":"Cancer"},{"key":"10.1053\/ejso.2002.1328_RF75","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1200\/JCO.1994.12.11.2288","article-title":"Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma","volume":"12","author":"Kemeny","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1328_RF76","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1200\/JCO.2000.18.2.243","volume":"18","author":"Lorenz","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1328_RF77","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1200\/JCO.1997.15.7.2589","article-title":"Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy","volume":"15","author":"Leyvraz","year":"1997","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798302913284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798302913284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:54:43Z","timestamp":1554166483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798302913284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S0748798302913284"],"URL":"https:\/\/doi.org\/10.1053\/ejso.2002.1328","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}